Hihara, F.; Matsumoto, H.; Yoshimoto, M.; Masuko, T.; Endo, Y.; Igarashi, C.; Tachibana, T.; Shinada, M.; Zhang, M.-R.; Kurosawa, G.;
et al. In Vitro Tumor Cell-Binding Assay to Select High-Binding Antibody and Predict Therapy Response for Personalized 64Cu-Intraperitoneal Radioimmunotherapy against Peritoneal Dissemination of Pancreatic Cancer: A Feasibility Study. Int. J. Mol. Sci. 2022, 23, 5807.
https://doi.org/10.3390/ijms23105807
AMA Style
Hihara F, Matsumoto H, Yoshimoto M, Masuko T, Endo Y, Igarashi C, Tachibana T, Shinada M, Zhang M-R, Kurosawa G,
et al. In Vitro Tumor Cell-Binding Assay to Select High-Binding Antibody and Predict Therapy Response for Personalized 64Cu-Intraperitoneal Radioimmunotherapy against Peritoneal Dissemination of Pancreatic Cancer: A Feasibility Study. International Journal of Molecular Sciences. 2022; 23(10):5807.
https://doi.org/10.3390/ijms23105807
Chicago/Turabian Style
Hihara, Fukiko, Hiroki Matsumoto, Mitsuyoshi Yoshimoto, Takashi Masuko, Yuichi Endo, Chika Igarashi, Tomoko Tachibana, Mitsuhiro Shinada, Ming-Rong Zhang, Gene Kurosawa,
and et al. 2022. "In Vitro Tumor Cell-Binding Assay to Select High-Binding Antibody and Predict Therapy Response for Personalized 64Cu-Intraperitoneal Radioimmunotherapy against Peritoneal Dissemination of Pancreatic Cancer: A Feasibility Study" International Journal of Molecular Sciences 23, no. 10: 5807.
https://doi.org/10.3390/ijms23105807
APA Style
Hihara, F., Matsumoto, H., Yoshimoto, M., Masuko, T., Endo, Y., Igarashi, C., Tachibana, T., Shinada, M., Zhang, M.-R., Kurosawa, G., Sugyo, A., Tsuji, A. B., Higashi, T., Kurihara, H., Ueno, M., & Yoshii, Y.
(2022). In Vitro Tumor Cell-Binding Assay to Select High-Binding Antibody and Predict Therapy Response for Personalized 64Cu-Intraperitoneal Radioimmunotherapy against Peritoneal Dissemination of Pancreatic Cancer: A Feasibility Study. International Journal of Molecular Sciences, 23(10), 5807.
https://doi.org/10.3390/ijms23105807